Aug 5, 2026 04:05PM
Jul 22, 2026 04:35PM
Jul 22, 2026 04:35PM
Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Aug 6, 2025 04:05PM
Jul 10, 2025 08:30AM FDA grants orphan drug status to Arcus' quemliclustat for pancreatic cancer
Jul 10, 2025 08:30AM
Jun 3, 2025 06:55AM
May 6, 2025 04:05PM
Feb 25, 2025 04:05PM
Dec 22, 2024 04:00AM
Nov 6, 2024 04:22PM
Aug 8, 2024 04:05PM Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
Aug 1, 2024 08:00AM
May 9, 2023 04:05PM
Nov 2, 2022 04:02PM
May 11, 2022 06:45AM
Dec 30, 2021 11:32AM
Nov 18, 2021 09:25AM
Sep 17, 2021 09:28AM Pre-Open Stock Movers 09/17: (CRVS) (ABCL) (BGNE) Higher; (PTGX) (GRTS) (X) Lower (more...)
Jul 19, 2021 05:19PM
Jun 24, 2021 09:26AM
Feb 24, 2021 04:10PM
Jan 15, 2021 08:05AM
Jan 15, 2021 08:03AM
Jan 11, 2021 05:03PM
Jan 6, 2021 04:10PM Arcus Biosciences Appoints Biotech Industry Veteran, Andrew Perlman, M.D., Ph.D. and Gilead’s SVP of Research Biology, Michael Quigley, Ph.D. to Its Board of Directors
Dec 29, 2020 07:42AM
Nov 13, 2020 07:10AM
May 27, 2020 08:44AM
May 12, 2020 06:20AM
May 5, 2020 04:10PM
Apr 16, 2020 09:19AM
Mar 5, 2019 04:10PM Arcus Biosciences Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Updates
Aug 6, 2018 04:05PM
Jul 30, 2018 08:00AM
Jun 11, 2018 07:32AM
Jun 11, 2018 07:30AM

327,801 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All